Nasal vestibulitis due to targeted therapies in cancer patients

BACKGROUND AND PURPOSE: Cancer patients treated with targeted therapies (e.g., epidermal growth factor receptor inhibitors) are susceptible to dermatologic adverse events (AEs) including secondary skin infections. Whereas infections such as paronychia and cellulitis have been reported, nasal vestibu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Support Care Cancer
Hlavní autoři: Ruiz, Janelle N., Belum, Viswanath Reddy, Boers-Doets, Christine B., Kamboj, Mini, Babady, N. Esther, Tang, Yi-Wei, Valdez, Tulio A., Lacouture, Mario E.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4536911/
https://ncbi.nlm.nih.gov/pubmed/25876156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-014-2580-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky